26
Participants
Start Date
January 31, 2007
Primary Completion Date
October 31, 2010
Study Completion Date
May 31, 2012
irinotecan hydrochloride
vincristine sulfate
iobenguane I 131
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus, Atlanta
University of Chicago Comer Children's Hospital, Chicago
Cook Children's Medical Center - Fort Worth, Fort Worth
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Lucile Packard Children's Hospital at Stanford University Medical Center, Palo Alto
Children's Hospital and Regional Medical Center - Seattle, Seattle
Childrens Hospital Los Angeles, Los Angeles
Children's Hospital Boston, Boston
C.S. Mott Children's Hospital at University of Michigan Medical Center, Ann Arbor
Cincinnati Children's Hospital Medical Center, Cincinnati
Children's Hospital of Philadelphia, Philadelphia
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison
National Cancer Institute (NCI)
NIH
Children's Hospital Los Angeles
OTHER